COMPANY PROFILE

Trait Biosciences

Explore full profile

Emerging cannabis biotechnology company

Santa Fe, United StatesFounded 2017Biotech & Life Sciences

Valuation $100–250M Last recorded · 2021

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Trait Biosciences

Trait Biosciences is a biotechnology leader specializing in the hemp industry, focusing on cannabinoid production technologies. The company transforms scientific research into groundbreaking advances, particularly in the development of water-soluble CBD extracts. These extracts are designed to revolutionize the market for infused foods, beverages, cosmetics, and supplements. Trait Biosciences serves B2B clients, including manufacturers and brands looking to incorporate high-quality, purer, and safer hemp-derived products into their offerings. Operating primarily in the biotechnology and hemp markets, the company leverages its expertise in fermentation, metabolic engineering, bioinformatics, and computational biology to create innovative solutions. The business model revolves around licensing its proprietary technologies and selling its CBD extracts to various industries. Revenue is generated through these licensing agreements and direct sales of their products.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2017
Headquarters: Santa Fe, United States
Employees: 20
Open positions: None listed
Dealroom signal: 81.2/100
Industry: Health
Sub-industry: Pharmaceutical
Sector: Biotech & Life Sciences, Biotechnology, Cannabis, Spinout, Biotech and Pharma, DT and LS, science-based
Business model: Manufacturing
Client focus: b2c
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

9 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
EARLY VC✓Equity / VC	Sep 2023	—	—	Gotham Green Partners · Btomorrow Ventures	↗
SERIES AEquity / VC	Nov 2022	$0	—	Btomorrow Ventures	—

Showing the latest 2 of 9 recorded eventsBook a demo for the full funding history →

Growth signals

Trait Biosciences website traffic

Latest recorded traffic for Trait Biosciences is 690 monthly website visits, up 475% over the last three months. Trait Biosciences's team grew 0% over the past year.

Latest monthly visits690 3-month web change+475% 1-year team growth0%

Monthly website visitsJun 2018–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
AFAelis FarmaBiotech company conducting research and development on innovative signaling specific drugs	Bordeaux, France	Operational	27	$29M	$13M
IBInVivo BiosystemsAccelerating deep in-vivo insights into human biology and enable researchers to develop and deliver solutions that improve human health	Eugene, United States	Operational
PDPathogen DXDevelops a microarray based test specifically designed for the cannabis, botanical, food and agricultural testing markets	Scottsdale, United States	Operational
XIXINTEZACannabinoid and Psychedelic Active Ingredients	Tel Aviv-Yafo, Israel	Operational
OBOctarine BioHarnessing the powers of synthetic biology to develop rare and superior cannabinoids and psychedelic derivatives	Copenhagen, Denmark	Operational
FBFranklin BioscienceCannabis holding company acquiring and operating licensed assets	Denver, United States	Operational
OVOVAXFentanyl vaccine technologies to prevent overdoses, focusing on prediction, prevention, and protection	Houston, United States	Operational
TPTME PharmaDeveloping novel therapies for treatment of the most aggressive cancers by acting on the tumor microenvironment (TME)	Berlin, Germany	Operational